PubRank

Marta Perek-Polnik

Author PubWeight™ 14.36‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Subgroup-specific structural variation across 1,000 medulloblastoma genomes. Nature 2012 4.13
2 Cytogenetic prognostication within medulloblastoma subgroups. J Clin Oncol 2014 1.56
3 OTX1 and OTX2 expression correlates with the clinicopathologic classification of medulloblastomas. J Neuropathol Exp Neurol 2006 1.39
4 TERT promoter mutations are highly recurrent in SHH subgroup medulloblastoma. Acta Neuropathol 2013 1.35
5 Heterozygous germ-line mutations in the NBN gene predispose to medulloblastoma in pediatric patients. Acta Neuropathol 2009 0.87
6 Patterns of failure in children with medulloblastoma treated with 3D conformal radiotherapy. Radiother Oncol 2007 0.83
7 Gait pathology assessed with Gillette Gait Index in patients after CNS tumour treatment. Gait Posture 2010 0.79
8 Thymic carcinoma in children: a report from the Polish Pediatric Rare Tumors Study. Pediatr Blood Cancer 2010 0.78
9 The frequency of NBN molecular variants in pediatric astrocytic tumors. J Neurooncol 2009 0.78
10 Contrast enhancement pattern predicts poor survival for patients with non-WNT/SHH medulloblastoma tumours. J Neurooncol 2015 0.76
11 [Can proton magnetic resonance spectroscopy be of any value as a prognostic factor in medulloblastoma?]. Med Wieku Rozwoj 2003 0.76
12 Functional status of children after treatment for a malignant tumour of the CNS: a preliminary report. Gait Posture 2006 0.75
13 [Brain tumors in children]. Przegl Lek 2003 0.75
14 [Malignant vascular tumours in children -- report from the Polish Pediatric Rare Tumors Study]. Med Wieku Rozwoj 2005 0.75
15 [Treatment results of patients over 3 years of age with medulloblastoma]. Med Wieku Rozwoj 2003 0.75
16 [Treatment results of children and adolescents with brain stem tumours. Own experiences]. Med Wieku Rozwoj 2007 0.75
17 [Cancer among adolescents 15-19 years of age. Own experience]. Med Wieku Rozwoj 2007 0.75
18 [Thymoma and thymic carcinoma--review of literature and clinical characteristics based on the Polish Paediatric Solid Tumours Study Group experience]. Med Wieku Rozwoj 2008 0.75
19 [Rare tumours--are they really rare in the Polish children population?]. Przegl Lek 2004 0.75
20 ALK Expression Is a Novel Marker for the WNT-activated Type of Pediatric Medulloblastoma and an Indicator of Good Prognosis for Patients. Am J Surg Pathol 2017 0.75
21 Retrospective multi-institutional study on hemangiopericytoma in Polish children. Pediatr Int 2009 0.75